Phenylephrine per se or Combined with Pregabalin Ameliorates Mononeuropathic Pain in Rats

<b>Background/Objectives:</b> Neuropathic pain (NP) affects approximately 6.9–10% of the population and is inadequately managed by the current therapies, as reflected by a high number needed to treat (NNT). These data highlight the socio-economic burden of NP on healthcare. Thus, the repurposing of...

詳細記述

書誌詳細

主要な著者:	Sarah Kadhim Abbood, Nariman Essmat, Imre Boldizsár, Judit Mária Kirchlechner-Farkas, Csenger Kovácsházi, Yashar Chalabiani, Kornél Király, Ildikó Miklya, Zoltán Giricz, Laszlo G. Harsing, E. Sylvester Vizi, Mahmoud Al-Khrasani
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2026-03-01
シリーズ:	Pharmaceutics
主題:	phenylephrine noradrenaline release pregabalin/phenylephrine combination neuropathic pain
オンライン･アクセス:	https://www.mdpi.com/1999-4923/18/3/334
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!